Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Pfizer
PFE
|
$1.44B |
| 2 |
Eli Lilly
LLY
|
$878M |
| 3 |
Blackstone
BX
|
$707M |
| 4 |
RTX Corp
RTX
|
$596M |
| 5 |
American Express
AXP
|
$553M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$3.55B |
| 2 |
American Tower
AMT
|
$1.27B |
| 3 |
Amazon
AMZN
|
$735M |
| 4 |
TSS
Total System Services, Inc.
TSS
|
$714M |
| 5 |
NextEra Energy, Inc.
NEE
|
$621M |
Sector Composition
| 1 | Healthcare | 21.49% |
| 2 | Financials | 15.09% |
| 3 | Technology | 13.78% |
| 4 | Industrials | 11% |
| 5 | Consumer Discretionary | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Sun Life Financial
SLF
$32.4B
| $321K | ﹤0.01% |
7,172
+551
| +8% | +$24.7K |
|
|
DCPH
1877
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $320K | ﹤0.01% |
+9,431
| New | +$320K |
|
1878
Canadian Imperial Bank of Commerce
CM
$72.8B
| $319K | ﹤0.01% |
7,714
-93,002
| -92% | -$3.85M |
|
1879
Deutsche Bank
DB
$67.8B
| $310K | ﹤0.01% |
41,312
-9,937
| -19% | -$74.6K |
|
1880
Goodyear
GT
$2.43B
| $303K | ﹤0.01% |
21,000
-60,224
| -74% | -$869K |
|
1881
KalVista Pharmaceuticals
KALV
$796M
| $303K | ﹤0.01% |
+26,069
| New | +$303K |
|
1882
Home Federal Bancorp
HFBL
$42.2M
| $300K | ﹤0.01% |
18,360
| – | – |
|
1883
Fox Class B
FOX
$24.9B
| $295K | ﹤0.01% |
+9,341
| New | +$295K |
|
1884
News Corp Class A
NWSA
$16.6B
| $293K | ﹤0.01% |
21,079
-99,398
| -83% | -$1.38M |
|
1885
ResMed
RMD
$40.6B
| $292K | ﹤0.01% |
+2,161
| New | +$292K |
|
1886
Sonos
SONO
$1.78B
| $289K | ﹤0.01% |
+21,520
| New | +$289K |
|
|
CURO
1887
DELISTED
CURO Group Holdings Corp.
CURO
| $289K | ﹤0.01% |
21,758
-2,480
| -10% | -$32.9K |
|
1888
Fresh Del Monte Produce
FDP
$1.72B
| $287K | ﹤0.01% |
+8,419
| New | +$287K |
|
1889
Innospec
IOSP
$2.13B
| $287K | ﹤0.01% |
+3,214
| New | +$287K |
|
1890
W.W. Grainger
GWW
$47.5B
| $285K | ﹤0.01% |
960
-4,935
| -84% | -$1.47M |
|
1891
Ziff Davis
ZD
$1.56B
| $281K | ﹤0.01% |
+3,559
| New | +$281K |
|
1892
Canadian Pacific Kansas City
CP
$70.3B
| $275K | ﹤0.01% |
6,185
+40
| +0.7% | +$1.78K |
|
1893
Progress Software
PRGS
$1.88B
| $271K | ﹤0.01% |
7,137
-30,344
| -81% | -$1.15M |
|
|
CS
1894
DELISTED
Credit Suisse Group
CS
| $269K | ﹤0.01% |
22,000
| – | – |
|
1895
United Therapeutics
UTHR
$18.1B
| $253K | ﹤0.01% |
3,181
-730
| -19% | -$58.1K |
|
1896
Cheniere Energy
LNG
$51.8B
| $252K | ﹤0.01% |
+3,983
| New | +$252K |
|
1897
Apogee Enterprises
APOG
$939M
| $251K | ﹤0.01% |
+6,427
| New | +$251K |
|
1898
Virtus Investment Partners
VRTS
$1.31B
| $251K | ﹤0.01% |
+2,266
| New | +$251K |
|
1899
BorgWarner
BWA
$9.53B
| $244K | ﹤0.01% |
7,536
+2,012
| +36% | +$65.1K |
|
1900
AnaptysBio
ANAB
$613M
| $239K | ﹤0.01% |
6,830
-2,243
| -25% | -$78.5K |
|